全球神經修復和再生市場規模、佔有率、成長分析（按類型、按應用） - 產業預測，2024-2031 年

Global Nerve Repair and Regeneration Market Size, Share, Growth Analysis, By Type(Neurostimulation and Neuromodulation Devices, and Biomaterials), By Application(Peripheral Nerve Injury, Epilepsy) - Industry Forecast 2024-2031

出版日期: 2024年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球神經修復和再生市場規模為82億美元，從2023年的92億美元成長到2031年的230.5億美元，預測期內（2024-2031年）年複合成長率為12.17%。

全球神經系統疾病的盛行率不斷上升，如帕金森氏症、阿茲海默症和各種中樞神經系統（CNS）疾病，推動了全球市場的上升趨勢。受影響人數的迅速增加推動了對有效治療方案的需求不斷成長。醫療領域的主要企業正在積極努力加強產品平臺，以滿足不斷成長的需求，並推動旨在提高神經系統疾病治療有效性的技術進步。相信這些措施將大大促進市場拓展。此外，各種中樞神經系統疾病治療方案的激增正在擴大市場格局。特別是，使用工程神經移植物的治療方法在恢復患有上肢神經病變的患者的運動和感覺神經功能方面顯示出有希望的結果。在美國手外科學會年會上發表的一項研究顯示，接受某些神經移植治療的患者中，75% 的患者運動功能恢復，85% 的感覺恢復。此外，大眾對神經系統疾病的認知不斷提高，再加上環境影響、生活方式選擇、遺傳、營養和身體傷害等因素，人們對這些疾病有了更好的了解。這種意識的提高極大地促進了對神經修復和再生解決方案不斷成長的需求。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

美敦力（美國）
波士頓科學公司（美國）
雅培實驗室（美國）
史賽克公司（美國）
AxoGen, Inc.（美國）
Integra LifeSciences Holdings Corporation（美國）
百特國際公司（美國）
Nevro 公司（美國）
LivaNova PLC（英國）
Cyberonics Inc.（美國）
Orthofix 醫療公司（美國）
Polyganics（荷蘭）
Nuvectra 公司（美國）
Polyganics BV（荷蘭）
BioTime 公司（美國）
Collagen Matrix, Inc.（美國）
Synovis Micro Companies Alliance, Inc.（美國）
StimGuard LLC（美國）
Nexeon MedSystems Inc.（美國）
Checkpoint Surgical, Inc.（美國）

簡介目錄

Product Code: SQMIG35I2162

Global Nerve Repair And Regeneration Market size was valued at USD 8.2 Billion in 2022 and is poised to grow from USD 9.2 Billion in 2023 to USD 23.05 Billion by 2031, at a CAGR of 12.17% during the forecast period (2024-2031).

The upward trajectory of the global market is fueled by the escalating prevalence of neurological disorders worldwide, including Parkinson's disease, Alzheimer's, and various Central Nervous System (CNS) disorders. This surge in afflicted individuals has spurred a heightened demand for effective treatment options. Major players in the medical sector are actively involved in bolstering their product pipelines to meet this escalating demand, channeling significant efforts into research and development endeavors to drive technological advancements aimed at enhancing the efficacy of neurological disorder treatments. These strides are poised to substantially fuel market expansion. Furthermore, the proliferation of therapeutic options for diverse CNS disorders amplifies market prospects. Notably, therapies utilizing processed nerve allografts have exhibited promising outcomes in reinstating motor and sensory nerve functions among patients grappling with upper extremity nerve impairments. A study presented at the annual meeting of the American Society for Surgery of the Hand revealed that 75% of patients treated with a specific nerve allograft witnessed motor function recovery, with 85% experiencing restored sensory nerve function. Additionally, heightened public awareness regarding neurological disorders, coupled with factors encompassing environmental influences, lifestyle choices, genetics, nutrition, and physical injuries, has cultivated a deeper understanding of these conditions. This augmented awareness has notably contributed to the escalating demand for nerve repair and regeneration solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair And Regeneration Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair And Regeneration Market Segmental Analysis

Global Nerve Repair and Regeneration Market is segmented by Type, application, and region. Based on Type, the market can be segmented into neurostimulation and neuromodulation devices, and biomaterials. Based on application, the market is segmented into peripheral nerve injury, epilepsy, Parkinson's disease, and Alzheimer's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Nerve Repair And Regeneration Market

A major catalyst propelling the nerve repair and regeneration market forward is the escalating prevalence of neurological disorders worldwide, encompassing ailments like Alzheimer's disease, Parkinson's disease, and spinal cord injuries. As the frequency of these conditions rises, there's a pressing requirement for efficient treatment avenues, thus spurring an upsurge in the demand for nerve repair and regeneration therapies. This momentum is fueled by various factors including aging demographics, shifts in lifestyles, environmental impacts, and genetic susceptibilities, all underscoring the imperative for inventive solutions within the market.

Restraints in the Global Nerve Repair And Regeneration Market

A key challenge within the nerve repair and regeneration sector is the substantial expense linked to cutting-edge treatments and therapies. The advancement and adoption of innovative technologies and regenerative approaches necessitate significant investments in research, development, and production. These expenses can create significant hurdles for patients seeking access, particularly in areas with constrained healthcare resources or insufficient insurance coverage. Moreover, the reimbursement environment for nerve repair and regeneration procedures may not consistently favor affordability and accessibility for patients.

Market Trends of the Global Nerve Repair And Regeneration Market

A notable trend in the nerve repair and regeneration sector involves a heightened emphasis on regenerative medicine and stem cell therapies. Both researchers and companies are delving into the capabilities of stem cells to stimulate nerve regrowth and revive neurological functions, presenting a promising avenue for patients grappling with nerve injuries or degenerative conditions. Stem cell-based methods present the opportunity to replenish damaged or lost cells, offering hopeful prospects for innovative treatments tailored to individual needs, thereby indicating the industry's movement towards regenerative and personalized therapeutic approaches.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Nerve Repair and Regeneration Market by Type

Market Overview
Neurostimulation and Neuromodulation Devices
and Biomaterials

Global Nerve Repair and Regeneration Market by Application

Market Overview
Peripheral Nerve Injury
Epilepsy
Parkinson's Disease
and Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AxoGen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvectra Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTime Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synovis Micro Companies Alliance, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StimGuard LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexeon MedSystems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Checkpoint Surgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments